Postdoctoral Associate – Molecular Genetics (57494)

first_imgA Postdoctoral Associate position is available in the Laboratoriesof Neurogenetics & Neuroscience (LNN) in the McKnight BrainInstitute at the University of Florida, focused on geneticdeterminants of brain health and disease. The research is fundedand directed by Prof. Matt Farrer in the Department of Neurology.Over the past 20 years, our team has helped define the geneticetiology of neurodegeneration using a combination of population andpedigree-based molecular genetics (high-throughput sequencing,genotyping and Sanger sequencing), bioinformatics (vcf tools,galaxy, python, perl, java) and applied statistics (R archive,(Plink, Beagle, linkage software). Dr. Farrer is best known for hiscontributions to Parkinson’s disease. The discoveries and insightsgained have improved diagnosis and have led to insightful models toadvance novel therapeutics into clinical trials.The successful applicant would join a team studying the majormolecular genetic determinants of neurologic disease and severalprojects are available (depending upon the aptitude and skill setof the applicant). The appointment represents a superb trainingopportunity to learn/apply a variety of molecular genetic,bioinformatic and statistical techniques for new Fellows or forSenior Fellows looking to make the transition to independentFaculty appointment.LNN is located in a vibrant neuroscience research atmosphere thatincludes the Center for Translational Research in NeurodegenerativeDisease, the Biomedical Sciences Center, the Center forNeurogenetics, the McKnight Brain Institute and the Fixel Institutefor Neurologic Disorders. The successful applicant will joindedicated, experienced and highly motivated teams. The research isfast-paced and exciting, the laboratories are modern andwell-equipped, and there are superb opportunities for advancedtraining in relevant techniques.A recent PhD, MD or MD/PhD, and experience in a field directlyrelevant to human genetics, molecular and/or population genetics.Applicants should have excellent oral and written communicationskills, and experience in the collection and analysis of data.Preferred candidates will have a strong record of productivity fromprevious training. They must have a high level of independence inthe design and execution of in vitro and in vivoexperiments. The position is initially available for one year withthe possibility of annual extensions. Salary will be commensuratewith experience and qualifications.Applications should include a CV, cover letter of intent, and alist of 3 references with contact information. Review ofapplications will begin immediately and will continue untilposition is filled. Questions may be directed to Dr. Matt Farrer [email protected] ; however,applications must be submitted online.All candidates for employment are subject to a pre-employmentscreening which includes a review of criminal records, referencechecks, and verification of education.The selected candidate will be required to provide an officialtranscript to the hiring department upon hire. A transcript willnot be considered “official” if a designation of “Issued toStudent” is visible. Degrees earned from an educational institutionoutside of the United States require evaluation by a professionalcredentialing service provider approved by the National Associationof Credential Evaluation Services (NACES), which can be found at http://www.naces.org/ .The University of Florida is an equal opportunity institutiondedicated to building a broadly diverse and inclusive faculty andstaff. Searches are conducted in accordance with Florida’s SunshineLaw. If an accommodation due to disability is needed in order toapply for this position, please call (352) 392-2477 or the FloridaRelay System at (800) 955-8771 (TDD).#category=35The University of Florida is committed to non-discrimination withrespect to race, creed, color, religion, age, disability, sex,sexual orientation, gender identity and expression, marital status,national origin, political opinions or affiliations, geneticinformation and veteran status in all aspects of employmentincluding recruitment, hiring, promotions, transfers, discipline,terminations, wage and salary administration, benefits, andtraining.last_img read more

Cherry AB unifies all igaming assets under ComeOn business area

first_img Affiliate leaders confirmed for CasinoBeats Malta 2020 February 21, 2020 Share Submit StumbleUpon Related Articles Bethard exits UK online gambling scene  June 17, 2020 Swedish CEOs challenge ‘unrealistic demands’ against threat of igaming becoming obsolete June 8, 2020 Share Anders HolmgrenHaving completed its outright acquisition of Malta-based European online casino operator ComeOn, Stockholm-listed Cherry AB has announced that it will unify its industry igaming portfolio under the acquired ComeOn brand.Confirming its restructuring decision, Cherry AB governance stated that all Cherry iGaming B2C assets, would be moved to the ComeOn brand as of 1 April 2017, with the firm creating a new  ComeOn business division.Updating investors on the organisational restructure, Cherry detailed that its decision would ‘re-emphasise its operational independence, aligning with other business areas owned and built up by Cherry AB.’New Cherry AB Chief Executive Anders Holmgren detailed to stakeholders “By clearly branding this business area we are, just as with XCaliber, Game Lounge and Yggdrasil, being even more clear and specific about how we build shareholder value, while supporting and acknowledging the diverse needs of each of our business areas,”Jonas Wåhlander CEO of ComeOn welcomed the decision by Cherry, stating  “We are building a business area, merging Cherry iGaming and ComeOn !, with some brands within it and setting a new unified culture and actionable values. We, therefore, wanted to take this opportunity to have a really good think about what name mirrors this the best. After spending some time we weren’t able to point to any brand alternative being on par or better than ComeOn!. It’s simply a great name and perfectly summarises our cultural attitude,”last_img read more